Search Results - Offin M

  • Showing 1 - 1 results of 1
Refine Results
  1. 1
    Cover Image

    Entrectinib: an orally available, selective tyrosine kinase inhibitor for the treatment of NTRK, ROS1, and ALK fusion-positive solid tumors by Liu D, Offin M, Harnicar S, Li BT, Drilon A

    Published 2018
    Connect to this object online.
    Book

    Save to List
    Saved in:

Search Tools: